Skip to content

Effects of virtual reality mindfulness interventions on depression and anxiety: a meta-analysis

Xiuchuan He, Yuanli Ren, Qian Bian, Yajing Wang, Xiaojing Wang

European Journal of Psychotraumatology May 26, 2026 DOI: 10.1080/20008066.2026.2664277 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Meta-analysis Randomized Peer reviewed
Sample size 864
Population Participants in randomized controlled trials of VR-based mindfulness interventions for depression and/or anxiety
Intervention VR-based mindfulness interventions
Topics Anxiety Depression Meditation
Keywords Virtual reality Mindfulness therapy Meta-analysis Realidad virtual
Key findings VR-based mindfulness interventions were associated with significant reductions in depressive and anxiety symptoms, with larger effects among older adults and in Eastern regions.

Abstract

Background: Depression and anxiety are common mental health problems that frequently co-occur with trauma-related disorders and often develop following traumatic or stressful events, substantially impairing quality of life. Mindfulness-based interventions have been shown to reduce these symptoms; however, their widespread implementation is often limited by poor accessibility and low adherence. Virtual reality (VR) may enhance mindfulness delivery through immersive experiences, but the overall efficacy of VR-based mindfulness interventions and the factors influencing their effectiveness remain unclear.Objective: This exploratory meta-analysis aimed to evaluate the effectiveness of VR-based mindfulness interventions in reducing depressive and anxiety symptoms and to explore potential moderators (population, region, immersion level, and intervention duration).Methods: A systematic literature search was conducted in PubMed, Web of Science and other databases up to 2025. Randomized controlled trials (RCTs) investigating VR-based mindfulness interventions for depression and/or anxiety were included. Meta-analyses were conducted using RevMan 5.4, calculating standardized mean differences (SMDs) with 95% confidence intervals (CIs).Results: Fifteen RCTs involving 864 participants were included. VR-based mindfulness interventions were associated with significant reductions in depressive and anxiety symptoms. Subgroup analyses indicated larger effect sizes among older adults (SMD = −1.40, p = .005) and in studies conducted in Eastern regions (SMD = −1.07, p < .00001). Both immersive and semi-immersive VR formats were effective. Interventions of short duration (≤4 weeks) and moderate duration (>6 to ≤8 weeks) showed benefits, and session lengths of ≤30 min were associated with greater symptom reduction (SMD = −0.93, p = .005).Conclusions: This exploratory meta-analysis suggests that VR-based mindfulness interventions are associated with reductions in depression and anxiety symptoms, moderated by intervention duration and regional cultural context. These findings support the potential of VR-based mindfulness as an accessible adjunctive approach, though high-quality studies with longer follow-up are needed to confirm sustained effects and improve generalizability.

Comparable studies

Other systematic reviews and meta-analyses on anxiety, most cited first.

Study Year Design Participants
Meditation Programs for Psychological Stress and Well-being Diverse adult clinical populations 2014 Meta-analysis n = 3,515
Research Review: The effects of mindfulness‐based interventions on cognition and mental health in children and adolescents – a meta‐analysis of randomized controlled trials Children and adolescents 2018 Systematic review and meta-analysis n = 3,666
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Patients with cancer- or illness-related anxiety and depression, major depressive... 2020 Systematic review n = 188
Does Mindfulness Meditation Improve Anxiety and Mood Symptoms? A Review of the Controlled Research Clinical populations with medical and emotional disorders 2007 Systematic review n = 15
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Patients from included clinical trials 2016 Systematic review

Citations in the library

Explore topics